Heart failure with reduced ejection fraction (HFrEF) still has significant morbidity and mortality despite the advancements in medical and device therapy (1). In the West, the most common cause of left ventricular dysfunction is coronary artery disease (CAD) (1). The management of patients with severe left ventricular systolic dysfunction (LVSD) and significant CAD without a clear indication for revascularisation, such as acute coronary syndrome (ACS) or angina, has divided cardiology opinion.
Author Sub-editor: Dr Joshua Rowland Dr Joshua Rowland is a cardiology registrar working in the North West Deanery. He graduated from the University of Manchester
Author Sub-editor: Dr Atmadeep Banerjee Dr Atmadeep Banerjee is an ST4 Cardiology Registrar in the Kent, Surrey and Sussex deanery. He graduated from Calcutta National
Authors Heartbeat Sub-Editor: Sandeep Singh Dr Sandeep Singh is a Cardiology Clinical Fellow at Nottingham University Hospitals NHS Trust. After graduating from India, he completed
Authors Heartbeat Sub-Editor: Khin Kay Kay Kyaw I am currently working as cardiology specialist registrar ST6 at southwest peninsula region while also working as an